Eagle Health Investments LP Vertex Pharmaceuticals Inc Transaction History

Eagle Health Investments LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $19.3 Million - $24 Million	-82,144 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$177.01 - $223.45 $9.31 Million - $11.8 Million	52,600 Added 178.04%	82,144 $18 Million
Q3 2021 Oct 20, 2021	SELL	$181.39 - $202.99 $7.36 Million - $8.24 Million	-40,600 Reduced 57.88%	29,544 $5.36 Million
Q2 2021 Jul 19, 2021	SELL	$187.49 - $221.1 $3.43 Million - $4.05 Million	-18,300 Reduced 20.69%	70,144 $14.1 Million
Q1 2021 Apr 23, 2021	BUY	$207.02 - $241.31 $7.54 Million - $8.79 Million	36,444 Added 70.08%	88,444 $19 Million
Q4 2020 Feb 04, 2021	BUY	$207.01 - $276.09 $10.8 Million - $14.4 Million	52,000 New	52,000 $12.3 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Eagle Health Investments LP, based on Form 13F filings with the SEC.

Stay updated on Eagle Health Investments LP with notifications on news.